
China's Jiangsu province pledged support on Wednesday for pharmaceutical companies pursuing foreign acquisitions, licensing agreements, and joint development projects. The provincial initiative arrives as Beijing tightens regulatory scrutiny over sensitive technologies and cross-border commercial transactions.

